SCREENER COMPARE ANY 2 STOCKS

EARNINGS CALL ARCHIVE 4 CALLS ON FILE

GMAB — Genmab A/S

NASDAQ

FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 8, 2025

REVENUE

$1.02B +10.5%

NET MARGIN

39.2% +2.9 PTS

EPS

$0.65 +20.4%

FREE CASH FLOW

$534.0M +927.1%

No summary has been written for this call yet.